Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Shares Outstanding (Weighted Average) (2016 - 2025)

Skinvisible (SKVI) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1093.32% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Dec 2025, up 1093.32% year-over-year, with the annual reading at $5.4 million for FY2025, 1093.32% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $5.4 million in Q4 2025 for Skinvisible, roughly flat from $5.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $5.4 million in Q2 2025 to a low of $60000.0 in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $4.3 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 7466.41% in 2021 and later crashed 90.04% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then plummeted by 90.04% to $452000.0 in 2024, then soared by 1093.32% to $5.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SKVI at $5.4 million in Q4 2025, $5.4 million in Q3 2025, and $5.4 million in Q2 2025.